To more accurately assess the true contribution of PSAP/Sap C to PCa disease progression (especially metastasis and therapeutic resistance) and validate its translational potential as a therapeutic target, future research must leverage more advanced and physiologically relevant model systems. This evidence concerns the gene PSAP and posterior cortical atrophy.